ANIP
ANI Pharmaceuticals Inc
72.20$
-1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +39.1% | -59.2% | -4.7% | -28.4% | +27.1% | +120.6% | +116.7% | -41.9% | -31.1% | +92.2% | -2.9% | – | |
| – | -0.1% | -3.3% | +0.1% | +7.2% | +43.5% | +1.3% | +1.7% | -2.8% | -0.1% | -7.5% | -6.1% | – | |
| – | +3.3% | +23.4% | +13.4% | -4.8% | -5.7% | +25.6% | +8.3% | +0.9% | +0.8% | +4.3% | +111.9% | – | |
| – | +399.4% | -136.8% | – | – | -157.4% | – | +2,626.6% | -149.2% | – | – | +1,575.4% | – | |
| – | +5.0% | -4.1% | -2.9% | +8.2% | -48.5% | +700.2% | -65.2% | -10.8% | +287.1% | -52.5% | +0.0% | – | |
| – | +5.0% | – | -149.8% | +8,857.6% | -97.3% | +85.8% | -65.2% | -10.8% | -77.2% | +707.1% | -73.0% | – | |
| – | +0.0% | +0.0% | +0.2% | -0.2% | +0.0% | +0.0% | +0.2% | -15.5% | -100.0% | – | – | – | |
| – | -65.5% | +3,649.4% | -85.0% | -47.7% | -53.2% | +3,045.6% | -94.5% | +89.5% | -41.5% | +3,133.2% | -95.9% | – | |
| – | – | – | – | – | -100.6% | +0.0% | +0.0% | +0.0% | +100.0% | +0.0% | 0.0% | – | |
| – | -417.4% | +65.5% | -92.6% | – | -101.7% | +101.9% | -82.4% | – | -173.1% | +366.3% | -78.5% | – | |
| – | -10.6% | -73.3% | +54.0% | -926.0% | – | – | +1,275.9% | -34.1% | -48.7% | +11.4% | +91.6% | – | |
| – | +44.7% | -65.7% | -5.3% | -40.9% | +74.6% | +13.2% | +355.0% | -45.0% | -82.8% | +623.1% | +44.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.